New Zealand Weighs Diabetes, Dementia Risk Warnings On Statin Labels
This article was originally published in PharmAsia News
Executive Summary
New Zealand authorities are considering adoption of a warning on statin drugs similar to that of the U.S. FDA advising they could increase the risk of diabetes and dementia.